General Information of This Metabolic Reaction (MR) (ID:
MR002253) |
Formula |
|
Reactant |
Sildenafil citrate |
Product |
N-dealkyl Sildenafil |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 3A4 (CYP3A4)
|
DME Info
|
Mephenytoin 4-hydroxylase (CYP2C19)
|
DME Info
|
Cytochrome P450 2D6 (CYP2D6)
|
DME Info
|
Cytochrome P450 2C9 (CYP2C9)
|
DME Info
|
Cytochrome P450 3A5 (CYP3A5)
|
DME Info
|
Cytochrome P450 2E1 (CYP2E1)
|
DME Info
|
Metabolic Type
|
Oxidation
-
N-Dealkylation
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
References |
1 |
The contributions of cytochromes P450 3A4 and 3A5 to the metabolism of the phosphodiesterase type 5 inhibitors sildenafil, udenafil, and vardenafil. Drug Metab Dispos. 2008 Jun;36(6):986-90.
|
2 |
Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality. Br J Clin Pharmacol. 2002;53 Suppl 1(Suppl 1):5S-12S. doi: 10.1046/j.0306-5251.2001.00027.x.
|
3 |
Erectile dysfunction drugs changed the protein expressions and activities of drug-metabolising enzymes in the liver of male rats. Oxid Med Cell Longev. 2016;2016:4970906.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.